Post by VectorY

Thank you to the ENCALS 2026 organizers for coordinating an engaged and inspiring ALS community. We were pleased to share an update on our VTx-002 program targeting TDP-43 in ALS at the TRICALS Satellite Symposium. Through collaboration, shared scientific insight, and ongoing innovation, we are working together to advance new potential therapies that target the underlying drivers of ALS, with the goal of transforming patient care. #VectorY #ALS #ALSResearch #ALSCommunity #ClinicalTrials #NeurodegenerativeDiseases #vectorizedantibodies #AntibodyTreatments #AntibodyTechnology #ENCALS2026